title: Implementation of proteomic biomarkers: making it work.
abstract: While large numbers of proteomic biomarkers have been described, they are generally not implemented in medical practice. We have investigated the reasons for this shortcoming, focusing on hurdles downstream of biomarker verification, and describe major obstacles and possible solutions to ease valid biomarker implementation. Some of the problems lie in suboptimal biomarker discovery and validation, especially lack of validated platforms with well-described performance characteristics to support biomarker qualification. These issues have been acknowledged and are being addressed, raising the hope that valid biomarkers may start accumulating in the foreseeable future. However, successful biomarker discovery and qualification alone does not suffice for successful implementation. Additional challenges include, among others, limited access to appropriate specimens and insufficient funding, the need to validate new biomarker utility in interventional trials, and large communication gaps between the parties involved in implementation. To address this problem, we propose an implementation roadmap. The implementation effort needs to involve a wide variety of stakeholders (clinicians, statisticians, health economists, and representatives of patient groups, health insurance, pharmaceutical companies, biobanks, and regulatory agencies). Knowledgeable panels with adequate representation of all these stakeholders may facilitate biomarker evaluation and guide implementation for the specific context of use. This approach may avoid unwarranted delays or failure to implement potentially useful biomarkers, and may expedite meaningful contributions of the biomarker community to healthcare.
authors.affiliation: BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Harald.Mischak@glasgow.ac.uk
authors.forename: Harald
authors.initials: H
authors.lastname: Mischak
authors.forename: John P A
authors.initials: JP
authors.lastname: Ioannidis
authors.forename: Angel
authors.initials: A
authors.lastname: Argiles
authors.forename: Teresa K
authors.initials: TK
authors.lastname: Attwood
authors.forename: Erik
authors.initials: E
authors.lastname: Bongcam-Rudloff
authors.forename: Mark
authors.initials: M
authors.lastname: Broenstrup
authors.forename: Aristidis
authors.initials: A
authors.lastname: Charonis
authors.forename: George P
authors.initials: GP
authors.lastname: Chrousos
authors.forename: Christian
authors.initials: C
authors.lastname: Delles
authors.forename: Anna
authors.initials: A
authors.lastname: Dominiczak
authors.forename: Tomasz
authors.initials: T
authors.lastname: Dylag
authors.forename: Jochen
authors.initials: J
authors.lastname: Ehrich
authors.forename: Jesus
authors.initials: J
authors.lastname: Egido
authors.forename: Peter
authors.initials: P
authors.lastname: Findeisen
authors.forename: Joachim
authors.initials: J
authors.lastname: Jankowski
authors.forename: Robert W
authors.initials: RW
authors.lastname: Johnson
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Julien
authors.forename: Tim
authors.initials: T
authors.lastname: Lankisch
authors.forename: Hing Y
authors.initials: HY
authors.lastname: Leung
authors.forename: David
authors.initials: D
authors.lastname: Maahs
authors.forename: Fulvio
authors.initials: F
authors.lastname: Magni
authors.forename: Michael P
authors.initials: MP
authors.lastname: Manns
authors.forename: Efthymios
authors.initials: E
authors.lastname: Manolis
authors.forename: Gert
authors.initials: G
authors.lastname: Mayer
authors.forename: Gerjan
authors.initials: G
authors.lastname: Navis
authors.forename: Jan
authors.initials: J
authors.lastname: Novak
authors.forename: Alberto
authors.initials: A
authors.lastname: Ortiz
authors.forename: Frederik
authors.initials: F
authors.lastname: Persson
authors.forename: Karlheinz
authors.initials: K
authors.lastname: Peter
authors.forename: Hans H
authors.initials: HH
authors.lastname: Riese
authors.forename: Peter
authors.initials: P
authors.lastname: Rossing
authors.forename: Naveed
authors.initials: N
authors.lastname: Sattar
authors.forename: Goce
authors.initials: G
authors.lastname: Spasovski
authors.forename: Visith
authors.initials: V
authors.lastname: Thongboonkerd
authors.forename: Raymond
authors.initials: R
authors.lastname: Vanholder
authors.forename: Joost P
authors.initials: JP
authors.lastname: Schanstra
authors.forename: Antonia
authors.initials: A
authors.lastname: Vlahou
mesh_terms: D015415:Biomarkers; D035843:Biomedical Research / Q000379:methods*; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000379:methods; D006801:Humans; D040901:Proteomics
chemical_list: D015415:Biomarkers